このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Early Mobilization and No Urinary Catheter After Cesarean for Improved Post Operative Recovery: A Randomized Trial

2026年9月28日 更新者:Bnai Zion Medical Center

Impact of Promoting Early Mobilization and Eliminating Urinary Catheterization on Post-Cesarean Recovery: A Randomized Control Trial

ERAS (Enhanced Recovery After Surgery) is a set of steps used around surgery to help patients recover faster and better. ERAS guidelines have been adopted in several surgical fields, and evidence-based recommendations have recently been developed for cesarean delivery as well.

These guidelines address multiple parts of post-operative care, including prevention of nausea and vomiting, pain control, thromboprophylaxis, early mobilization, urinary catheter use, and discharge counseling.

Early mobilization is a key element of ERAS, but there is currently limited high-quality evidence about its specific benefits after cesarean delivery. In theory, mobilizing earlier may reduce thromboembolic events, shorten hospitalization, and speed up return of bowel function.

Another important ERAS component is avoiding routine urinary catheter use. Evidence suggests that a no-catheter policy can shorten the time to first mobilization, first eating, and first bowel movement, and can reduce overall hospital stay compared with routine catheter use around cesarean delivery. In a randomized controlled trial of 300 women assigned to immediate versus delayed (12-hour) catheter removal after cesarean delivery, immediate removal reduced bacteriuria and urinary symptoms (dysuria, frequency, urgency), and also shortened time to first mobilization and length of stay. A systematic review also found that inserting a catheter before cesarean delivery increases the risk of urinary tract infection without improving surgical ease. A 2014 Cochrane review concluded that routine catheter use increases time to first urination, increases discomfort, delays mobilization, and prolongs hospital stay.

The aim of the present study is to compare early mobilization combined with no urinary catheter in women undergoing planned cesarean delivery versus standard perioperative care, to improve recovery after surgery.

調査の概要

状態

完了

条件

詳細な説明

Procedure

According to our department policy, the protocol for women undergoing a planned cesarean delivery includes prophylactic intravenous antibiotics with cefazolin 2 g given within 60 minutes of the start of surgery, together with 500-1000 mL of lactated Ringer's solution before surgery. Spinal anesthesia is then performed using 10 mg hyperbaric bupivacaine with 100 micrograms intrathecal morphine. Immediately afterward, a Foley urinary catheter is inserted into the bladder.

The surgical technique is at the discretion of the surgeon and is usually performed using the Misgav Ladach method. During the operation, the patient receives intravenous ondansetron to prevent nausea and vomiting, and phenylephrine is given to treat episodes of hypotension. Skin closure is performed using a continuous subcuticular suture. After surgery, the woman receives thromboprophylaxis according to her risk factors. Eight hours after surgery, the urinary catheter is removed and the woman gets out of bed for the first time, accompanied by a nurse, to go to the toilet or shower.

All women receive scheduled, around-the-clock analgesia during the first 24 hours: 1,000 mg intravenous paracetamol plus 400 mg ibuprofen every 8 hours, with the option to add dipyrone, tramadol, or morphine for breakthrough pain according to the VAS score. After that, pain treatment is given on request. Women are usually discharged on postoperative day 3.

A woman who agrees to participate in the study will sign an informed consent form and will be randomized to one of two groups. Women in the control group will receive the routine care described above. The intervention group will receive different perioperative care: no urinary catheter will be inserted, and the woman will be asked to void immediately before transfer to the operating room. Preoperative fluids will be limited to 200-300 mL of lactated Ringer's, and the woman will receive phenylephrine during surgery to maintain blood pressure. After surgery, the woman will get out of bed after 4 hours for her first void and to shower. All other perioperative care will be identical to the control group, including antibiotics, spinal anesthesia, pain control, and antithrombotic prophylaxis.

Randomization will be performed according to a computerized list, and allocation will be placed in an opaque, sequentially numbered envelope. After the patient signs the consent form, the envelope will be opened.

-

Data collection

Demographic and obstetric data will be collected from the women's medical records. The primary outcome will be a composite outcome that includes: the QoR-15 (Quality of Recovery 15) questionnaire score completed 24 hours after delivery, the number of steps during the first 24 hours as counted by a smartwatch , and opioid consumption beyond the scheduled regimen during the first postoperative day. A positive outcome will be recorded if the participant meets 2 of the following 3 criteria:

  1. QoR-15 score > 118
  2. More than 454 steps per day (one standard deviation below the mean)
  3. Opioid consumption during the first 24 hours after surgery (beyond the scheduled regimen)

Secondary outcomes will include the number of steps in the first 24 hours, and VAS pain scores at 2, 4, 8, 12, 24, and 48 hours. VAS scores at 4 and 8 hours will be recorded at rest and immediately after the first mobilization. Additional secondary outcomes will include inability to mobilize to the shower after the first time out of bed, patient satisfaction, use of analgesics, breastfeeding and time to first breastfeeding, intraoperative and postoperative complications, and length of hospital stay. Intraoperative complications will include bladder or bowel injury and postpartum hemorrhage. Postoperative complications will include urinary retention, need for blood transfusion, wound infection, endometritis, urinary tract infection, paralytic ileus, hematoma requiring drainage, need for repeat laparotomy, and readmission during the first two weeks after surgery.

-

Sample size calculation

Assuming a composite outcome rate of 80% in the control group, and a hypothesized clinically meaningful improvement of 15% in the intervention group, with an alpha error of 5% and power of 80%, the calculated sample size is 260 participants (130 in each group).

研究の種類

介入

入学 (実際)

260

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

受講資格のある性別

女性

説明

Inclusion Criteria:

  • elective surgery
  • Singleton

Exclusion Criteria:

  • placenta accreta
  • Limited mobility
  • Allergy to nsaids/paracetamol/optalgin

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
介入なし:Control

Urine catheter at surgery and regular ambulation after 8 hours

実験的:enhanced ERAS

Omission of urinary catheter and early ambulation after 4 hours

Omission of urinary catheter and early ambulation

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Enhanced recovery
時間枠:24 hours

composite outcome scoring positive on 2/3 components: Recovery questionnaire score above 118, step count above 454 and non opioid use

24 hours

二次結果の測定

結果測定
メジャーの説明
時間枠
Inability to Ambulate on First Postoperative Attempt
時間枠:At first postoperative ambulation attempt- between 4-8 hours postoperative

Number of participants unable to ambulate on the first attempted postoperative ambulation.

At first postoperative ambulation attempt- between 4-8 hours postoperative
Pre and post ambulation Pain Score on the Visual Analog Scale
時間枠:Immediately before and after first postoperative ambulation

Pain assessed immediately before and after first ambulation using a Visual Analog Scale from 0 to 10, where 0 indicates no pain and 10 indicates worst pain. Higher scores indicate greater pain.

Immediately before and after first postoperative ambulation
Postoperative Pain Score at 2-12 Hours
時間枠:2-12 hours after surgery

Score at 2, 4, 8, 12 Hours Pain assessed using a Visual Analog Scale from 0 to 10, where 0 indicates no pain and 10 indicates worst pain. Higher scores indicate greater pain.

2-12 hours after surgery
Maternal Satisfaction Score at 24 Hours and 1 week after surgery and in comparison to previous Cesarean Section
時間枠:24 hours and 1 week after surgery

Maternal satisfaction assessed on a 1-10 scale, where higher scores indicate greater satisfaction.

24 hours and 1 week after surgery
Post-surgical Complication Within 7 Days of surgery
時間枠:From surgery through postoperative day 7

Number of participants with one or more post-surgical complications during the first postoperative week and specification of each complication

From surgery through postoperative day 7
Hospital Length of Stay
時間枠:From surgery/delivery through hospital discharge

Number of days from surgery/delivery to hospital discharge.

From surgery/delivery through hospital discharge
Participants Rehospitalized Within 1 Week
時間枠:From discharge/surgery through postoperative day 7

Number of participants rehospitalized within 1 week after surgery.

From discharge/surgery through postoperative day 7
Neonates With Late Neonatal Complications Within 7 Days
時間枠:Birth through neonatal day 7

Number of neonates with late neonatal complications and specification of the different complications that occurred.

Birth through neonatal day 7
breastfeeding at 1 day and 1 week after surgery
時間枠:1 day and 1 week postpartum

number of participants breastfeeding at 1 day and 1 week postpartum among women who intended to breastfeed. Women not interested in breastfeeding were excluded from this analysis.

1 day and 1 week postpartum
Participants Rehospitalized Within 1 Week
時間枠:Rehospitalization within a week after discharge

Number of participants rehospitalized within 1 week after surgery.

Rehospitalization within a week after discharge
Post-surgical Complication Within 7 Days of surgery
時間枠:Day of surgery through postoperative day 7

Number of participants with one or more post-surgical complications during the first postoperative week and specification of each complication

Day of surgery through postoperative day 7

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2021年10月21日

一次修了 (実際)

2025年1月6日

研究の完了 (実際)

2025年9月10日

試験登録日

最初に提出

2026年4月26日

QC基準を満たした最初の提出物

2026年9月28日

最初の投稿 (実際)

2026年10月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年10月1日

QC基準を満たした最後の更新が送信されました

2026年9月28日

最終確認日

2021年10月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • REC-SP-CS-001

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified individual participant data (including data dictionary) will be shared. Requests may be submitted to liannapinsky@gmail.co. Access will be provided to qualified researchers for analyses under a data use agreement.

IPD 共有時間枠

May 2026

IPD 共有アクセス基準

ualified researchers may request access to de-identified individual participant data and supporting information by contacting the study team at liannapinsky@gmail.com. Requests will be reviewed by the investigators, and access will be granted for scientifically valid research purposes after approval of the request and completion of a data access/use agreement.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • CSR

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する